Ignite Creation Date:
2024-05-06 @ 10:27 AM
Last Modification Date:
2024-10-26 @ 12:30 PM
Study NCT ID:
NCT03267940
Status:
TERMINATED
Last Update Posted:
2020-02-07
First Post:
2017-07-25
Brief Title:
Study of PEGPH20 With Cisplatin CIS and Gemcitabine GEM PEGPH20 With Atezolizumab ATEZO CIS and GEM and CIS and GEM Alone in Participants With Previously Untreated Unresectable Locally Advanced or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma
Sponsor:
Halozyme Therapeutics
Organization:
Halozyme Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Cholangiocarcinoma Non-resectable |
| Cholangiocarcinoma Intrahepatic |
| Cholangiocarcinoma Extrahepatic |
| Gallbladder Adenocarcinoma |